Found: 16
Select item for more details and to access through your institution.
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05827-x
- By:
- Publication type:
- Article
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 669, doi. 10.1007/s00432-022-04416-0
- By:
- Publication type:
- Article
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 8, p. 2077, doi. 10.1007/s00432-020-03290-y
- By:
- Publication type:
- Article
Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 8, p. 1886, doi. 10.1007/s12094-024-03408-5
- By:
- Publication type:
- Article
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 7, p. 2389, doi. 10.1245/s10434-020-08219-w
- By:
- Publication type:
- Article
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41011-4
- By:
- Publication type:
- Article
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3631, doi. 10.3390/cancers14153631
- By:
- Publication type:
- Article
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.751453
- By:
- Publication type:
- Article
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 5, p. 863, doi. 10.1002/ijc.34760
- By:
- Publication type:
- Article
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE‐3).
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 11, p. 1935, doi. 10.1002/ijc.33747
- By:
- Publication type:
- Article
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 8, p. 1919, doi. 10.1002/ijc.33364
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 836, doi. 10.1038/s41416-022-01854-y
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- 2022
- By:
- Publication type:
- journal article
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Recurrent Intracranial Ewing Sarcoma.
- Published in:
- Ochsner Journal, 2024, v. 24, n. 3, p. 213, doi. 10.31486/toj.24.0014
- By:
- Publication type:
- Article
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
- Published in:
- Medical Oncology, 2022, v. 39, n. 6, p. 1, doi. 10.1007/s12032-022-01700-4
- By:
- Publication type:
- Article